Abstract:The present research compares the stability, catalytic activity, and cardioprotective benefits of the designed superoxide dismutase (SOD) variation SOD-M3 to those of the naturally occurring enzyme, along with additional alternatives. SOD-M3 exhibited a 51.5 % increase in expression yield, reaching 50 mg/L, compared to the wild-type's 33 mg/L. In structural biology, the average distance between atoms of stacked proteins or molecules is measured by RMSD. Testing the precision of protein-ligand docking models is a typical application. The projected structure closely resembles the reference or native structure when the RMSD is low. The enzyme's durability improved significantly, resulting in negligible aggregation in the Size Exclusion Chromatography (SEC) and root mean square deviation (RMSD) of 2.1 Å. SOD-M3 catalytically increased superoxide radical scavenging capability by 40 % and inhibited nitroblue tetrazolium (NBT) reduction by 90 % at 1 μg/mL concentration. The material exhibited increased stability, as seen by its decomposition temperature (Tm) of about 80 °C, as opposed to 65 °C in the wild-type strains. In cardiomyocyte protection experiments, SOD-M3 reduced lactate dehydrogenase (LDH) production by 55 % while decreasing reactive oxygen species (ROS) concentrations by 60 %. Since a 51.5 % increase in expression yield for SOD-M3 indicates improved production efficiency, which makes large-scale manufacturing more viable for clinical applications, it is therapeutically essential. Higher expression yields mean more cost-effective manufacture for enzyme-based therapy research and commercialization. In vivo, SOD-M3 decreased myocardial infarction diameter by 44 % while improving cardiac function, including increased ejection percentage and fractional contraction. The histopathological investigation revealed undamaged heart tissue and less necrotic areas. The results reported here demonstrate SOD-M3's superior activity of enzymes, cardioprotective perspective, and stability, making it a promising therapeutic alternative for illnesses related to cellular oxidation & ischemic cardiac diseases. An increase in enzyme concentrations can enhance the obtaining of reactive oxygen species (ROS), which build up during ischaemia episodes; therefore, this increase is essential. Improving the enzyme's solubility and stability by site-directed modifications makes SOD-M3 more stable and effective in physiological circumstances where its activity is crucial for therapeutic efficacy maximization. A further benefit of increased expression yield is that it can lower manufacturing costs, which will help get SOD-M3 into clinical settings. These modifications raise SOD-M3's cardioprotective potential, making it a strong contender for novel therapies against cardiac ischemia-reperfusion impacts.

The Protection of Enzyme Activity for the Preparation of Humanized Polymerized Hemoglobin-Superoxide Dismutase-Catalase-Carbonic Anhydrase

Effect of Activity Protectors on Protein Activity in Microspheres

Preliminary Study on Polymerization between Hemoglobin and Enzymes during the Preparation of PolyHb-SOD-CAT-CA

Preparation of microspheres of superoxide dismutase and their activities

The Preliminary Study on Preparation Technology of PolyHb-SOD-CATCA - The Effects of Different Extractants

Co-Immobilization of Superoxide Dismutase with Catalase on Soft Microparticles Formed by Self-Assembly of Amphiphilic Poly(Aspartic Acid)

Immobilization of Carbonic Anhydrase by Embedding and Covalent Coupling into Nanocomposite Hydrogel Containing Hydrotalcite

Polymer Conjugation to Cu,Zn-SOD and Suppression of Hydroxyl Radical Generation on Exposure to H2O2: Improved Stability of SOD in Vitro and in Vivo

Synthesis and Characterization of Poly(acrylic Acid‐co‐acrylamide)/hydrotalcite Nanocomposite Hydrogels for Carbonic Anhydrase Immobilization

Poly(acrylic acid)/Hydrotalcite Nanocomposite Hydrogels:Preparation,and Preliminary Immobilization Studies of Carbonic Anhydrase

Coupling and Regulation of Porous Carriers Using Plasma and Amination to Improve the Catalytic Performance of Glucose Oxidase and Catalase

Hemoglobin in Submicron Particles (HbMPs) Is Stabilized Against Oxidation

Preparation of Zwitterionic Polymer and Its Effect on Enzyme Activity

Innovative Engineering of Superoxide Dismutase for Enhanced Cardioprotective Biocatalysis in Myocardial Ischemia-Reperfusion Injury

Study on immobilization of SOD onto fiber-chitosan composite

Preparation and Characterization of pH-Sensitive Capsosomes for Oral Delivery of Therapeutic Proteins

Enzymatic Preparation and Protection Technology of Heme

Optimization of Enzymatic Preparation of Antioxidant Peptide from Porcine Hemoglobin

Stable Dried Catalase Particles Prepared by Electrospraying

Chemical Modification of Superoxide Dismutase by Low Molecular Weight Heparin and Their Physical and Chemical Properties

Activity and Stability of Chloroperoxidase in the Presence of Small Quantities of Polysaccharides: A Catalytically Favorable Conformation Was Induced